Gastroenterology

A highly interactive symposium, including pre-recorded interviews with patients, was chaired by Prof Geert D’Haens. Participation by the audience was…

IBD shows a progressive immunopathogenesis.1 Following an initial immune response, amplification of this inflammatory response leads to the phenotypic…

The epidemiology of diverticular disease (DD) is changing, with an increasing prevalence in younger patients from Europe and the USA, and changing disease…

Despite the fact that the treatment armamentarium for inflammatory bowel diseases (IBD) is growing, unmet medical needs remain…

The objectives of the symposium were to raise awareness of the importance of treating early, setting treatment goals, and using enhanced clinical…

Chemotherapy-induced mucositis is a common, often severe, side effect experienced by cancer patients during their treatment, which is a major challenge…

Colon cancer remains one of the leading causes of cancer-related morbidity and mortality worldwide and it is generally accepted that most colorectal…

The prevalence of non-cardiac chest pain (NCCP) ranges from 13–33%. A majority of those presenting with a chief complaint of chest pain are found to have…

Over the last half century, radiotherapy has been established as a very effective treatment modality for solid tumours. Large numbers of patients…

Infantile colic is a frustrating impasse that affects up to 20% of infants. Even though its pathogenesis is currently unknown, some…

Magnetic resonance cholangiopancreatography (MRCP) is an important diagnostic tool in evaluating patients with biliary laboratory abnormalities after…

Considering patient-reported outcomes (PRO) for optimal disease management is pivotal in many chronic diseases, and inflammatory bowel disease (IBD) is…

This symposium focusses on understanding the advantages and limitations of current management strategies for Crohn’s disease.

Inflammatory bowel disease (IBD) has a dramatic impact on patients and their families, as well as on society as a whole due to its significant economic…

The current treatment strategy for patients with inflammatory bowel disease (IBD) aims to enable physicians to deliver optimal care and to improve the…

Biosimilars have contributed substantially to the evolving therapeutic landscape for inflammatory bowel disease (IBD), enabling healthcare systems to…

Gastric cancer is the second most common cause of cancer-related deaths worldwide, and the 5-year overall survival rate for advanced gastric cancer is ≤25%.

Do flares of ulcerative colitis (UC) cause long-term bowel damage? Dr Sandborn opened the symposium by challenging the audience to think about their…

Given the progressive nature of Crohn’s disease (CD), Prof Panés made a case for timely intervention in at-risk patients to achieve the ultimate goal of…

Recent epidemiological data gathered by the Centers for Disease Control and Prevention (CDC) suggest that colorectal cancer (CRC) is the second leading…

Highlighting the importance of early diagnosis, assessing prognostic factors, and treating to target inflammatory bowel disease.

Abdominal tuberculosis and its protean manifestations still create a diagnostic challenge for clinicians and remain an important concern in the…

Since it was first identified in 1982, Helicobacter pylori has continued to draw attention far beyond its role in peptic ulcer disease and is now…

Fat accumulation in the pancreas, defined as fatty pancreas, is usually an incidental finding during transabdominal ultrasound examination.